Cells (Sep 2023)

The Potential Role of RANTES in Post-Stroke Therapy

  • Hanna Pawluk,
  • Renata Kołodziejska,
  • Grzegorz Grześk,
  • Alina Woźniak,
  • Mariusz Kozakiewicz,
  • Agnieszka Kosinska,
  • Mateusz Pawluk,
  • Magdalena Grześk-Kaczyńska,
  • Elżbieta Grzechowiak,
  • Jakub Wojtasik,
  • Grzegorz Kozera

DOI
https://doi.org/10.3390/cells12182217
Journal volume & issue
Vol. 12, no. 18
p. 2217

Abstract

Read online

One of the key response mechanisms to brain damage, that results in neurological symptoms, is the inflammatory response. It triggers processes that exacerbate neurological damage and create the right environment for the subsequent repair of damaged tissues. RANTES (Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted) chemokine(C-C motif) ligand 5 (CCL5) is one of the chemokines that may have a dual role in stroke progression involving aggravating neuronal damage and playing an important role in angiogenesis and endothelial repair. This study concerned patients with ischemic stroke (AIS), whose CCL5 concentration was measured at various time intervals and was compared with the control group. In addition, the effect of this biomarker on neurological severity and functional prognosis was investigated. Compared to healthy patients, a higher concentration of this chemokine was demonstrated in less than 4.5 h, 24 h and on the seventh day. Differences in CCL5 levels were found to be dependent on the degree of disability and functional status assessed according to neurological scales (modified Rankin Scale, National Institutes of Health Stroke Scale). In addition, differences between various subtypes of stroke were demonstrated, and an increase in CCL5 concentration was proven to be a negative predictor of mortality in patients with AIS. The deleterious effect of CCL5 in the acute phase of stroke and the positive correlation between the tested biomarkers of inflammation were also confirmed.

Keywords